The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Androgen receptors in endocrine‐therapy‐resistant human prostate cancer
Abstract
Despite the initial androgen‐dependent growth of most human prostate cancers, eventually all prostate cancers become androgen‐independent at varying intervals after androgen ablation or anti‐androgen therapy. In order to gain more insight into the role of the androgen receptor (AR) in this process, AR and prostate‐specific antigen (PA) expression was evaluated immunohistochemically in prostatic tumour tissues from patients who developed urinary flow obstruction between 4 and 107 months after onset of treatment. AR expression was evaluated with a monoclonal antibody (MAb) specific for the N‐ terminal domain of the human AR. To substantiate the progressive tumour growth, proliferative activity was assessed immunohistochemically by staining with MAb Ki‐67. Ki‐67‐defined tumour‐growth fractions varied from 0.8–64.7%. In 13 of the 17 examined tumours over 80% of the tumour cells were AR‐positive, 3 tumours showed a considerable heterogeneity in AR expression and in I tumour almost all tumour cells seemed to be AR‐negative. Two‐thirds of the examined tumours contained variable proportions of PA‐positive tumour areas. These observations contrast with the view that androgen ablation induces a preferential outgrowth of receptor‐negative tumour cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Lubahn, D. B., Joseph, D. R., Sar, M., Tan, J.-A., Higgs, H. N., Larson, R. E., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1265 · Cited by 570
Autologous Down-Regulation of Androgen Receptor Messenger Ribonucleic Acid
Quarmby, V. E., Yarbrough, W. G., Lubahn, D. B., French, F. S., & Wilson, E. M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-1-22 · Cited by 268
Use of human prostate-specific antigen in monitoring prostate cancer.
Kuriyama, M., Wang, M. C., Lee, C., Papsidero, L. D., Killian, C. S., Inaji, H., Slack, N. H., Nishiura, T., Murphy, G. P., & Chu, T. M. (1981) · PubMed · Cited by 192
Isaacs, J. T., Wake, N., Coffey, D. S., & Sandberg, A. A. (1982) · PubMed · Cited by 165
Veldscholte, J., Voorhorst-Ogink, M. M., Bolt-de Vries, J., van Rooij, H. C. J., Trapman, J., & Mulder, E. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90075-o · Cited by 162
Self-citationCharacterization of the Prostate-specific Antigen gene: A novel human kallikrein-like gene
Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Romijn, J. C., & Trapman, J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92409-1 · Cited by 160
Self-citationRundlett, S. E., Wu, X.-P., & Miesfeld, R. L. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-5-708 · Cited by 138
Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry
de Winter, J. A. R., Trapman, J., Brinkmann, A. O., Boersma, W. J. A., Mulder, E., Schroeder, F. H., Claassen, E., & van der Kwast, T. (1990) · The Journal of Pathology · doi:10.1002/path.1711600409 · Cited by 106
Self-citationZegers, N. D., Claassen, E., Neelen, C., Mulder, E., van Laar, J. H., Voorhorst, M. M., Berrevoets, C., Brinkmann, A. O., van der Kwast, T., de Winter, J. A. R., et al. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90178-j · Cited by 103
Self-citationTrapman, J., Ris‐Stalpers, C., van der Korput, J. A. G. M., Kuiper, G. G. J. M., Faber, P. W., Romijn, J. C., Mulder, E., & Brinkmann, A. O. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90429-o · Cited by 68
Self-citationMechanisms of normal and malignant breast epithelial growth regulation
Lippman, M. E., & Dickson, R. B. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90071-x · Cited by 62
Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
Quarmby, V. E., Beckman, W. C., Cooke, D. B., et al. (1990) · PubMed · Cited by 60
Nonomura, N., Nakamura, N., Uchida, N., Noguchi, S., Sato, B., Sonoda, T., & Matsumoto, K. (1988) · PubMed · Cited by 51
Diamond, D. A., & Barrack, E. R. (1984) · The Journal of Urology · doi:10.1016/s0022-5347(17)49881-8 · Cited by 48
Gallee, M. P. W., Gj, V. S., ten Kate, F. J. W., Schroeder, F. H., & van der Kwast, T. H. (1987) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/79.6.1333 · Cited by 27
Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC‐82
Gallee, M. P. W., van Vroonhoven, C. C. J., van der Korput, H. A., Kwast, T. H. D. V., ten Kate, F. J. W., Trapman, J., & Romijn, J. C. (1986) · The Prostate · doi:10.1002/pros.2990090107 · Cited by 26
Self-citation
Cited by
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M.-E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,253
Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082
Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Metadata
- Authors
- van der Kwast, T. H., Schalken, J., de Winter, J. A. R., van Vroonhoven, J. C. C., Mulder, E., Boersma, W., & Trapman, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1991-05-10
- Volume
- 48
- Issue
- 2
- Pages
- 189-193
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2008498145
- Cited by
- 386
- References
- 17
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.